Traws Pharma, Inc. |
Chief Operating Officer, Director |
Common Stock |
134K |
$63.1K |
$0.47 |
Apr 1, 2024 |
Direct |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Stock Option (right to purchase) |
3.8M |
|
|
Apr 1, 2024 |
Direct |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
4.8K |
|
|
Apr 1, 2024 |
By Viriom, Inc. |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
2.58K |
|
|
Apr 1, 2024 |
By TPAV, LLC |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
195 |
|
|
Apr 1, 2024 |
Direct |